A magic bullet for mucosal protection...and aspirin is the trigger!

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.7, 2003-07, pp. : 323-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA Therapeutics: the Next Magic Bullet?

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. : 467-474

Bentham Science Publishers

Access to resources Recommend Favorite

Aspirin/prasugrel: Oesophageal mucosal lesion: case report

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?

By Karamouzis Michalis V Papavassiliou Athanasios G

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 359-372

Informa Healthcare

Access to resources Recommend Favorite

Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?

Current Medicinal Chemistry, Vol. 16, Iss. 33, 2009-11 ,pp. : 4361-4373

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide, Aspirin-Triggered Lipoxins and NO-Aspirin in Gastric Protection

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 2, 2006-04 ,pp. : 133-137

Bentham Science Publishers

Access to resources Recommend Favorite